The largest database of trusted experimental protocols
> Chemicals & Drugs > Organic Chemical > Glycopyrrolate

Glycopyrrolate

Glycopyrrolate is a synthetic anticholinergic agent used to reduce salivary, tracheobronchial, and gastrointestinal secretions.
It has diverse medical applications, including treatment of peptic ulcers, irritable bowel syndrom, and certain respiratory conditions.
PubCompare.ai's AI-driven platform can help optimize research protocols and enhance reproducibility for Glycopyrrolate, allowing you to quickly locate the best procedures from literature, pre-prints, and patents.
Streamline your research process and ensure reliable results with PubCompare.ai's intelligent comparisons.

Most cited protocols related to «Glycopyrrolate»

Surgical induction of ischemic stroke injury was first optimized in 4 male landrace pigs and once optimized; this study was performed in 7 male Yucatan miniature pigs (5 years old; weighing between 80.9-104.5 kg with mean weight 93.6 kg).
All pigs were administered antibiotics 30 minutes prior to surgery (Ceftiofur sodium (Naxcel®; 4 mg/kg IM). Pre-induction analgesia and sedation was obtained using xylazine (5 mg/kg IM), butorphanol (0.2 mg/kg IM) and glycopyrrolate (0.01 mg/kg IM). Anesthesia was induced with intravenous propofol to effect and prophylactic lidocaine (0.5 to 1.0 mL of 2% lidocaine) was administered topically to the laryngeal folds to facilitate intubation. Anesthesia was maintained with 1.5% inhalational isoflurane (Abbott Laboratories) in oxygen. Artificial ventilation was performed at a rate of 8–12 breaths per minute with tidal volume of 5–10 ml/kg. With the animal positioned in sternal recumbency, a venous catheter was placed in the left aural vein for fluid therapy. During surgery, lactated ringers solution was administered at a rate of 5 ml/kg/hour. Heart rate was monitored by Doppler probe placement on the ventral tail artery. Rectal temperature was recorded every 15 minutes using a digital thermometer.
The head was tilted to the left 45 degrees and secured to facilitate a right MCA approach, utilizing gravity to lift the cerebrum away from the bony skull base during intracranial surgery. Hair between the eye and ear was shaved and the skin was prepared in a routine manner for sterile surgery using Betadine and 70% alcohol. The surgical site was draped in a standard fashion.
Full text: Click here
Publication 2014
Anesthesia Animals Antibiotics, Antitubercular Arteries Base of Skull Betadine Bones Butorphanol Catheters ceftiofur sodium Cerebral Hemispheres Condoms Ethanol Fingers Fluid Therapy Glycopyrrolate Gravity Hair Head Inhalation Injuries, Surgical Intubation Isoflurane Lactated Ringer's Solution Laryngeal Prosthesis Lidocaine Males Management, Pain Naxcel Operative Surgical Procedures Oxygen Pigs Propofol Rate, Heart Rectum Respiration, Artificial Respiratory Rate Sedatives Skin Sterility, Reproductive Sternum Stroke, Ischemic Tail Thermometers Tidal Volume Veins Xylazine

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2009
Anesthetic Gases Animals BLOOD Blood Pressure Body Temperature Brain Catheters Glycopyrrolate Head Intubation, Intratracheal Isoflurane Ketamine Macaca mulatta Normal Saline Pharmaceutical Preparations physiology Pulse Rate Radioactivity Radionuclide Imaging Reconstructive Surgical Procedures Rectum Respiration Signs, Vital Tomography Transmission, Communicable Disease Veins
All procedures were approved by the Institutional Animal Care and Use Committees at the University of Pennsylvania and the Michael J. Crescenz Veterans Affairs Medical Center and adhered to the guidelines set forth in the NIH Public Health Service Policy on Humane Care and Use of Laboratory Animals (2015).
For the current study, specimens were obtained from a tissue archive of castrated male pigs subjected to a single mild TBI. This tissue archive was also used in Grovola et al. (25 (link)). All pigs were 5 to 6 months old, sexually mature (considered to be young adult), Yucatan miniature pigs at a mean weight of 34 ± 4 kg (total n = 29, mean ± SD). Pigs were fasted for 16 hours then anesthesia was induced with 20 mg/kg of ketamine and 0.5 mg/kg of midazolam. Following induction, 0.1 mg/kg of glycopyrrolate was subcutaneously administered and 50 mg/kg of acetaminophen was administered per rectum. All animals were intubated with an endotracheal tube and anesthesia was maintained with 2% isoflurane per 2 liters O2. Heart rate, respiratory rate, arterial oxygen saturation, and temperature were continuously monitored throughout the experiment. A forced‐air temperature management system was used to maintain normothermia throughout the procedure.
In order to attain closed‐head diffuse mild TBI in animals, we used a previously described model of head rotational acceleration in pigs (26 (link), 27 (link)). Similar methods were described in Grovola et al. (25 (link)). Briefly, each animal's head was secured to a bite plate, which itself was attached to a pneumatic actuator and a custom assembly that converts linear motion into angular momentum. The pneumatic actuator rotated each animal's head in the coronal plane, reaching an angular velocity between 165 and 185 radians per second (rad/s) for the lower‐level injured group (n = 4) and 230–270 rad/s for the higher‐level injured group (n = 15). Any presence of apnea was recorded (maximum apnea time = 45 s), and animals were hemodynamically stabilized if necessary. No animals were excluded from the study due to apnea or hemodynamic instability. Sham animals (n = 10) underwent identical protocols, including being secured to the bite plate, however, the pneumatic actuator was not initiated. All animals were transported back to their housing facility, monitored acutely for 3 hours, and given access to food and water. Afterward, animals were monitored daily for 3 days by veterinary staff.
At 3 days post‐injury (DPI) (n = 4), 7 DPI (n = 4 at 165–185 rad/s; n = 5 at 230–270 rad/s), 30 DPI (n = 3), or 1‐year post‐injury (YPI) (n = 3), animals were induced and intubated as described above. Sham animals survived for 7 days (n = 4), 30 days (n = 1), or 1 year (n = 5). While under anesthesia, animals were transcardially perfused with 0.9% heparinized saline followed by 10% neutral buffered formalin (NBF). Animals were then decapitated, and tissue was stored overnight in 10% NBF at 4°C. The following day, the brain was extracted, weighed, and post‐fixed in 10% NBF at 4°C for 1 week. To block the tissue, an initial coronal slice was made immediately rostral to the optic chiasm. The brain was then blocked into 5 mm thick coronal sections from that point by the same investigator. This allowed for consistent blocking and section coordinates across animals. All blocks of tissue were paraffin‐embedded and 8 µm thick sections were obtained using a rotary microtome.
Four sections from each specimen––one containing striatal tissue (approximately 10 mm anterior to the optic chiasm), one containing anterior aspects of hippocampal tissue (approximately 10 mm posterior to the optic chiasm), one containing posterior aspects of hippocampal tissue (approximately 15 mm posterior to the optic chiasm), and one containing cerebellar tissue (approximately 35 mm posterior to the optic chiasm)––were used for the ensuing Amyloid Precursor Protein (APP) histological analysis. Additional histological analysis examined only two sections from each specimen––one containing anterior aspects of hippocampal tissue and one containing posterior aspects of hippocampal tissue, as these sections displayed increased APP pathology in specific neuroanatomical regions. Histological analysis of the corpus callosum only included sections with anterior hippocampal tissue, as sections with posterior hippocampal tissue did not contain corpus callosum.
For 3,3′‐Diaminobenzidine (DAB) immunohistochemical labeling, we used a protocol outlined in Johnson et al. (5 (link)). Briefly, slides were dewaxed in xylene, rehydrated in ethanol and de‐ionized water. Antigen retrieval was completed in Tris‐EDTA buffer pH 8.0 using a microwave pressure cooker then blocked with normal horse serum. Slides were incubated overnight at 4°C using either an anti‐mouse APP (22C11) (Millipore, MAB348, 1:80,000), an anti‐mouse GFAP (SMI‐22) (Millipore, NE1015, 1:12,000), or an anti‐rabbit Iba‐1 (Wako, 019‐19741, 1:4000) primary antibody. The following day, slides were rinsed in PBS and incubated in a horse anti‐mouse/rabbit biotinylated IgG secondary antibody (VECTASTAIN Elite ABC Kit, Vector Labs, PK‐6200). Sections were rinsed again, then incubated with an avidin/biotinylated enzyme complex (VECTASTAIN Elite ABC Kit), rinsed again, and incubated with the DAB enzyme substrate (Vector Labs, SK‐4100) for 7 min. Sections were counterstained with hematoxylin, dehydrated in ethanol, cleared in xylene, and finally coverslipped using cytoseal. All sections were stained in the same histological sample run. All sections were imaged and analyzed at 20× optical zoom using an Aperio CS2 digital slide scanner (Leica Biosystems Inc., Buffalo Grove, IL).
For Luxol Fast Blue (LFB) staining, slides were dewaxed in xylene, and rehydrated in ethanol and deionized water. Slides were placed in a solution of 0.1% Solvent Blue 38 (Sigma, S‐3382) and 95% ethanol warmed to 60°C for 4 h, then differentiated in a lithium carbonate solution followed by 70% ethanol. Slides were counterstained in cresyl violet solution (Sigma, C5042), dehydrated in ethanol, cleared in xylene, and finally coverslipped using cytoseal. All slides were stained for LFB in the same histological sample run.
To assess brain atrophy, we examined the size of the lateral ventricle during gross pathological evaluation at the level of our initial coronal slice made immediately rostral to the optic chiasm. To measure the ventricle‐to‐brain ratio, we drew a region of interest to contain all brain parenchyma followed by regions of interest containing the lateral ventricles to determine area using ImageJ software. Ventricle‐to‐brain ratio was calculated as the total ventricular area divided by total brain area, multiplied by 100 so that the ratio is reported in whole numbers.
For APP semi‐quantitative analysis, we initially characterized four specimens (three 7 DPI and one sham) and stained sections every 5 mm throughout the brain and brainstem for APP. Based on these slides, we identified six anatomical regions that contained APP pathology: periventricular white matter, striatum, ventral thalamus, dorsal thalamus, fimbria/fornix, and cerebellum. These regions were assessed by two blinded observers in the four previously described tissue sections for every specimen and given a 0–3 pathological burden score based on the amount of APP+ axons in the region (Figure 1A–C). The scores were summed then divided by the number of anatomical regions to provide a single, averaged pathological score for each specimen.
For astrocyte semi‐quantitative analysis, hippocampus and periventricular white matter were assessed in two sections per specimen, as well as inferior temporal gyrus and cingulate gyrus––two anatomical regions without APP pathology. We have adapted a semi‐quantitative scale from Sofroniew et al. to histologically classify the progressive severity of reactive astrocytes (28 (link)). Each region was given a 0–3 glial fibrillary acidic protein (GFAP) reactivity score based on cell body size and density of GFAP+ cells in the region (Figure 2A–D). The scores were summed then divided by the number of anatomical regions to provide a single, averaged reactivity score for each specimen.
For microglia cell density, Fiji software (National Institute of Health) was used to convert the ionized calcium‐binding adapter protein‐1 (Iba‐1)‐stained images to grayscale and perform color deconvolution, and then the “Analyze Particles” plugin was used to count cells in an automated fashion using an objective set of exclusion parameters (29 (link)). Particles less than 20 µm2 were excluded as these tended to be DAB‐stained microglial processes in the field of view, detached from a microglial cell body.
For Iba‐1 skeletal analysis, we employed methods similar to Morrison et al., who imaged three coronal brain sections per animal twice, once in each left and right hemisphere, for analysis (23 (link)). The current study imaged five 40× images per anatomical region for analysis. The number of images were determined by power analysis of pilot skeletal analysis data. Specifically for the pilot study, we analyzed one image in the hippocampal molecular layer from one animal at each time point post‐injury and calculated the effect sizes. A moderate effect size (Cohen's d = 0.50) was observed between several groups. Using this effect size, an a priori power analysis required a sample size of five images per animal to achieve a power of 0.80. To conduct skeletal analysis, all Iba‐1 positive cells in each 40× field were manually selected, and the image was deconvoluted using Fiji software. Bandpass filters, unsharp mask, and close plugins were applied before converting the image to binary, skeletonizing, and removing skeletons not overlaid with the manually selected cells (Figure S1). The Analyze Skeleton plugin was then applied to quantify the skeletal features such as number of process branches, junctions, process endpoints, and slab voxels in order to measure changes in microglia ramification (30 (link)). For each image, each feature was summed then divided by the total number of cells, thus providing a single field average normalized per cell. Therefore, we examined five values from five images in the same histological slide for each animal in each anatomical region, which serves as a repeated measure, regional analysis. Slab voxels were then multiplied by the volume of the voxel to calculate the summed process length per cell.
For LFB analysis, measurements of the superior to inferior extent of the corpus callosum were obtained at five points along the mediolateral extent: at its juncture with the cingulate gyrus in both hemispheres as the lateral boundaries, at the midline of the corpus callosum, and midway between the corpus callosum midline and these lateral boundaries. These five measurements were averaged for each specimen. To measure the color intensity of the staining, the RGB color components were measured in ImageJ on a 0–255 AU scale. The scale for the blue color component was then inverted so that a zero value would indicate the whitest color while a 255 value would indicate the bluest color.
Statistical analysis was performed using GraphPad Prism statistical software (GraphPad Software Inc. La Jolla, CA). Due to low sample size, the 230–270 rad/s injured group's APP, GFAP, Iba‐1 cell density, corpus callosum thickness, and LFB color intensity data were analyzed with a Kruskal–Wallis test and Dunn's multiple comparisons. Kruskal–Wallis test results are reported as (H (degrees of freedom) = H test statistic, p value). The 165–185 rad/s injured group's APP data were analyzed via a two‐tailed Mann–Whitney test. Mann–Whitney results are reported as (U = U test statistic, p value). Nonlinear regression lines were created via an exponential growth equation. Goodness of fit is quantified using the standard deviation of the residuals (Se), the vertical distance (in Y units) of the experimental data point from the regression line, with a lower Se score indicative of a better predictive model. The skeletal analysis was statistically assessed via one‐way analysis of variance (ANOVA) and Tukey's multiple comparisons test. One‐way ANOVA results are reported as (F (degrees of freedom numerator/degrees of freedom denominator) = F value, p value). Mean, standard deviation, and 95% confidence intervals were reported. Differences were considered significant if p < 0.05. As this was an archival study, power calculations were not used to determine the number of specimens for each experimental group; the current study used all available specimens exposed to a single mild TBI. The number of images chosen for skeletal analysis was determined by power analysis from a pilot study.
Publication 2021
Acceleration Acetaminophen Amyloid beta-Protein Precursor Anesthesia Animals Animals, Laboratory Antigens Apnea Arteries Astrocytes Atrophy Avidin Axon Body Regions Body Size Brain Brain Stem Buffaloes Calcium-Binding Proteins Cerebellum Cerebral Ventricles Cloning Vectors Corpus Callosum cresyl violet Dental Occlusion Edetic Acid Enzymes Equus caballus Ethanol Fimbria of Hippocampus Fingers Food Formalin Glial Fibrillary Acidic Protein Glycopyrrolate Gyrus Cinguli Head Heart Ventricle Hematoxylin Hemodynamics Human Body Immunoglobulin G Immunoglobulins Inferior Temporal Gyrus Injuries Institutional Animal Care and Use Committees Isoflurane Ketamine Lithium Carbonate Luxol Fast Blue MBS Males Mice, House Microglia Microtomy Microwaves Midazolam MLL protein, human Multienzyme Complexes Normal Saline Optic Chiasms Oxygen Saturation Paraffin Physiology, Cell Pigs Pressure prisma Rabbits Rate, Heart Respiratory Rate Seahorses Serum Skeleton Solvents Strains Striatum, Corpus Subthalamus Thalamus Tissues Tromethamine Ventricle, Lateral Veterans Vision White Matter White Person Xylene Young Adult
Before the surgery, animals were anesthetized with isoflurane (3% in oxygen for induction, and 1.5–2% for surgery to maintain a breathing frequency around 1 Hz). Body temperature was kept at 37.5 °C with a feed-back controlled blanket (Harvard Apparatus), and eyes were covered with eye ointment. Glycopyrrolate (0.01mg/kg body weight), dexamethasone (0.2mg/kg body weight), and ketoprofen (5mg/kg body weight) were administrated intramuscularly. Dexamethasone and ketoprofen were also administrated in two consecutive days following the surgery. The anesthetized animal was fixed on stereotaxic, and hair was removed from scalp with scissors and Nair. The scalp was further sterilized by alcohol wipes, and then cut open and removed to expose both parietal plates as well as the bregma and lambda. Sterile saline was applied to the skull immediately after the exposure, and it is critical to keep the entire bone surface covered by saline to insulate from air. Fascia and connective tissue on the skull were gently removed with forceps and sterile wet cotton tips to avoid any internal bleeding inside the brain. At this point, the whole skull was transparent, with blood vessels underneath visible with sharp edges. The saline covering the skull was then wiped completely dry with cotton tips, and the following actions were taken quickly before the bone turns opaque. Ultra-violet curable glue (Loctite 4305) was applied to the skull surface within 2 seconds afterwards. A sterile and dry round coverslip of 5-mm diameter (#1 thickness, Electron Microscopy Sciences) was placed on the skull, centered at 2.5 mm lateral, and 2 mm caudal from the bregma point. The coverslip was pressed closely against the skull surface by forceps to minimize the amount of glue between the coverslip and the skull. The glue was left to cure by itself for about 5 minutes without any ultra-violet light, during which time the skull transparency tends to increase visually. Afterwards, an ultra-violet light source (385–515nm, Bluephase Style 20i, Ivoclar vivadent) was used to completely cure the glue, with roughly 1s on and 1s off for 3s. The coverslip is necessary to keep the glue layer as thin as possible (down to ~10 μm at the thinnest part on the skull), and to form a flat interface to reduce aberration. The exposed part of the skull surrounding the coverslip was further covered with dental cement. Supplementary Fig. 1 shows an example of successful preparation. For awake imaging, a head-bar for head fixation during imaging was glued to the exposed parts of the skull surrounding the coverslip by metabond glue.
Publication 2018
Animals Blood Vessel Body Temperature Body Weight Bones Connective Tissue Cranium Dental Cements Dexamethasone Electron Microscopy Ethanol Fascia Forceps Glycopyrrolate Gossypium Hair Head Isoflurane Ivoclar Ketoprofen Loctite Neoplasm Metastasis Ointments Operative Surgical Procedures Oxygen Saline Solution Scalp Sterility, Reproductive Ultraviolet Rays Viola Vivadent

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2016
Acetylcholine Blood-Brain Barrier Cholinergic Receptors exo-2-(2'-fluoro-5'-pyridinyl)-7-azabicyclo(2.2.1)heptane Glycopyrrolate Gray Matter Hypersensitivity Muscarinic Antagonists Nausea Pharmaceutical Preparations Physostigmine Plasma Positron-Emission Tomography Radionuclide Imaging

Most recents protocols related to «Glycopyrrolate»

All experiments using rhesus macaques were approved by the Tulane Institutional Animal Care and Use Committee (Protocol Nos-3581 and 3781). The Tulane National Primate Research Center (TNPRC) is an Association for Assessment and Accreditation of Laboratory Animal Care International accredited facility (AAALAC #000594). The NIH Office of Laboratory Animal Welfare assurance number for the TNPRC is A3071-01. All clinical procedures, including administration of anesthesia and analgesics, were carried out under the direction of a laboratory animal veterinarian. Animals were anesthetized with ketamine hydrochloride for blood collection procedures. Intestinal pinch biopsies were performed by laboratory animal veterinarians. Animals were pre-anesthetized with ketamine hydrochloride, acepromazine, and glycopyrrolate, intubated and maintained on a mixture of isoflurane and oxygen. All possible measures were taken to minimize the discomfort of all the animals used in this study. Tulane University complies with NIH policy on animal welfare, the Animal Welfare Act, and all other applicable federal, state and local laws.
Full text: Click here
Publication 2023
Acepromazine Analgesics Anesthesia Animals Animals, Laboratory Biopsy BLOOD Glycopyrrolate Institutional Animal Care and Use Committees Intestines Isoflurane Ketamine Hydrochloride Macaca mulatta Oxygen Primates Veterinarian
PubMed, Medline, Embase, Web Of Science, Scopus, Cochrane database, China National Knowledge Internet (CNKI) database, and recent abstracts were independently searched by two authors to identify all available RCTs addressing the therapy of postoperative CRBD (Fig. 1). Inclusion criteria for relevant RTCs were following: (1) patients aged ≥ 18 years undergoing any types of urological surgeries requiring placement of urinary catheter; (2) at least one drug or intervention with placebo control; (3) report incidence or severity of postoperative CRBD with at least one of the following time frames: 0, 1, and 2 or 6 h postoperatively; (4) the severity of CRBD was described in detail, or the scoring criteria for severity definition were developed. In addition, some RCTs evaluating the effects of interventions in patients with CRBD were also included and analyzed. The aim of all All RCTs was to evaluate the effects of any of the following drugs or interventions, which were preoperatively and/or intraoperatively used: cholinergic antagonists, solanaceous alkaloids, dexmedetomidine, gabapentin, glycopyrrolate, butylscopolamine, ketamine, oxybutynin, solifenacin, darifenacin, tolterodine, tramadol, lidocaine-prilocaine cream, and resiniferatoxin. The penile nerve block was also included as a non-drug treatment because there were two RCTs describing its effect [15 (link), 16 (link)].

Preferred reporting items for systematic reviews and meta-analyses flow chart depicting the studies and abstracts included in the part of network meta-analysis of managing CRBD

Full text: Click here
Publication 2023
Butylscopolamine Cholinergic Antagonists darifenacin Dexmedetomidine Gabapentin Glycopyrrolate Ketamine Nerve Block oxybutynin Patients Penis Pharmaceutical Preparations Placebos Prilocaine, Lidocaine Reading Frames resiniferatoxin Solanaceous Alkaloids Solifenacin Tolterodine Tramadol Urinary Catheterization Urologic Surgical Procedures
After entry to the operating room, HR, BP, and peripheral oxygen saturation were recorded for all patients; subsequently, dexamethasone 0.1 mg/kg and glycopyrrolate 0.005 mg/kg were administered. After pre-oxygenation, propofol 2 mg/kg and rocuronium 0.8 mg/kg were administered. The anesthesia was maintained with desflurane and was adjusted according to the bispectral index (BIS) level goal, which is from 30 to 60.
In the case of the T group, the Ce of remifentanil before intubation was set to 5.0–7.0 ng/mL using the syringe pump with a Minto model (Orchestra® Base Primea, Fresenius Kabi, VL, France) [17 (link)]. During surgery, the patients’ BP and HR were monitored, and the Ce of remifentanil was adjusted within the range of 1.0–3.0 ng/mL. In the M group, 0.7–1 µg/kg of remifentanil was administered before intubation using an infusion pump (Terufusion® Infusion Pump, Terumo, Tokyo, Japan). During surgery, remifentanil was titrated within the range of 0.05–0.2 µg/min/kg against HR and BP within a 20% range of baseline measurements. In both groups, if vital signs could not be controlled by remifentanil alone, a vasoconstrictor (phenylephrine, 50 µg) or vasodilator (nicardipine, 500 µg) was administered.
Remifentanil was discontinued during skin closure, and desflurane was discontinued when the position was changed from lithotomy to supine after surgery, and glycopyrrolate 0.005 mg/kg and pyridostigmine 0.25 mg/kg were administered as reversal agents of neuromuscular blockers. At the end of surgery, fentanyl-based (17.5 µg/kg) intravenous patient-controlled analgesia was administered to all of the participants until POD2. Additional opioids or analgesics were administered when patients complained of pain with an NRS pain score of ≥3 or if the patient required analgesics. In the PACU, fentanyl was administered as a bolus dose of 1 µg/kg. On POD1, intravenous acetaminophen 750 mg and per os ibuprofen 200 mg were used, and on POD2, ibuprofen was administered alone.
Full text: Click here
Publication 2023
Acetaminophen Analgesics Analgesics, Opioid Anesthesia Cell Respiration Desflurane Dexamethasone Fentanyl Glycopyrrolate Ibuprofen Infusion Pump Intubation Neuromuscular Blocking Agents Nicardipine Operative Surgical Procedures Pain Patient-Controlled Analgesia Patients Phenylephrine Propofol Pyridostigmine Remifentanil Rocuronium Saturation of Peripheral Oxygen Signs, Vital Skin Syringes Vasoconstrictor Agents Vasodilator Agents
Standard ASA monitoring was applied during the surgery. On arrival at the operating theater, patients were administered 5 mg of dexamethasone and 0.2 mg of glycopyrrolate. Spontaneous breathing was maintained throughout the non-intubated VATS procedure. Continuous dexmedetomidine infusion was administered to all patients at a rate of 0.5–0.7 μg/kg/h following 10 min of a loading dose of 1 μg/kg. Propofol administration was initiated with effective site concentrations of 3.0 μg/mL and titrated to 2.0–4.0 μg/mL. In initially awake patients, the dose was titrated to achieve a modified Ramsay sedation (MRS) score between 4 (appears asleep; purposeful responses to verbal commands louder than a usual conversation or to light glabellar tap) and 5 (asleep; sluggish purposeful responses only to loud verbal commands or strong glabellar tap). After an appropriate sedation level was achieved based on MRS score, the bispectral index was monitored using electroencephalographic analysis (target at levels between 40 and 60) to ensure an adequate sedation level during the surgery. Remifentanil was simultaneously initiated at 0.5 ng/mL and titrated to within a range of 0.5–3.0 ng/mL to maintain a respiratory rate of ≥10 breaths/min.
Full text: Click here
Publication 2023
Dexamethasone Dexmedetomidine Electroencephalography Glycopyrrolate Light Operative Surgical Procedures Patients Propofol Remifentanil Respiratory Rate Sedatives Thoracic Surgery, Video-Assisted
No premedication was administered. Upon arrival in the OR, routine monitoring devices, including ECG lead II, pulse oximetry, non-invasive blood pressure and bispectral index, were applied. After confirming the patency of the peripheral intravenous (IV) route, remifentanil 0.1 μg/kg/min was initiated along with the rapid infusion of IV fluid. Thereafter, no further manipulation of the patient occurred in order to avoid overstressing the patient for 5–10 min. The hemodynamic parameters, including HR and mean arterial blood pressure (MAP), were measured twice at an interval of 3 min. The average value of two measurements was used as baseline value for hemodynamic comparison (T0).
After the IV injection of glycopyrrolate 0.2 mg, anesthesia was induced with propofol of 1–1.5 mg/kg IV over 30 s. If the patient was able to maintain a verbal response, propofol 10 mg IV was administered every 10 s. When loss of consciousness was confirmed, 1 MAC desflurane or sevoflurane in oxygen/air with a flow rate of > 5 L/min was administered via a face mask. To facilitate endotracheal intubation, rocuronium 0.6 mg/kg IV was administered along with lidocaine 30–40 mg IV to prevent injection pain. An end-tidal CO2 (ETCO2) level of 35–40 mmHg and a peak airway pressure of < 25 cm H2O were maintained with manual ventilation for 5 min. The patient’s tracheal was intubated using direct laryngoscopy or light wand, depending on the need for lumbar/thoracic or cervical spine surgery, respectively. Appropriate placement of the endotracheal tube was confirmed using bilateral chest auscultation and waveform observations of ETCO2. The ventilator was set to maintain ETCO2 between 35 and 40 mmHg with a tidal volume of 8 ml/kg.
Full text: Click here
Publication 2023
Anesthesia Auscultation Blood Pressure Cervical Vertebrae Chest Desflurane Face Glycopyrrolate Hemodynamics Intravenous Infusion Intubation, Intratracheal Laryngoscopy Lidocaine Light Lumbar Region Medical Devices Operative Surgical Procedures Oximetry, Pulse Oxygen Pain Patients Premedication Pressure Propofol Remifentanil Rocuronium Sevoflurane Tidal Volume Trachea

Top products related to «Glycopyrrolate»

The TTK 450 stage is a temperature-controlled sample holder designed for microscopy applications. It allows for the precise control and monitoring of sample temperature within a range of -196 to +600 °C.
Sourced in United States, United Kingdom, Germany, Japan, Switzerland, Canada, Israel, Sweden, China, France, Brazil, Australia, Cameroon, Spain, Belgium
Isoflurane is an inhaled anesthetic agent used to induce and maintain general anesthesia in medical and veterinary settings. It is a clear, colorless, and volatile liquid. Isoflurane functions as a potent and effective anesthetic by depressing the central nervous system, resulting in unconsciousness, analgesia, and muscle relaxation.
Sourced in United Kingdom
Bevespi® is a combination inhalation device that contains two active ingredients: glycopyrrolate and formoterol fumarate. It is designed for the maintenance treatment of chronic obstructive pulmonary disease (COPD).
Sourced in United States
Nichrome wire is a metal alloy composed of approximately 80% nickel and 20% chromium. It is known for its high electrical resistance and durability, making it a commonly used material in various applications, including laboratory equipment. Nichrome wire is valued for its ability to maintain its electrical properties at high temperatures.
Sourced in United Kingdom, Sweden, Belgium
Ultiva is a sterile, white to off-white, lyophilized powder for intravenous administration. Its active ingredient is remifentanil hydrochloride, a rapid-acting, potent opioid analgesic. Ultiva is indicated for the induction and maintenance of anesthesia and for the reduction of postoperative pain.
Sourced in United States
Grip Cement is a dental laboratory product. It is used to secure dental prostheses during the fabrication process.
Sourced in United States
Glycopyrrolate is a synthetic anticholinergic medication used as a pharmaceutical agent. It functions as a muscarinic receptor antagonist, blocking the effects of the neurotransmitter acetylcholine.
The Büchi 191 spray dryer is a laboratory-scale equipment designed for the drying of liquid samples. It features a drying chamber, an air heater, and a cyclone separator to collect the dried product. The 191 spray dryer can be used to process various types of liquid samples, such as solutions, suspensions, or emulsions, into dry powders or granules.
Sourced in United States
Glycopyrrolate is a synthetic anticholinergic agent used as a medication to reduce excessive saliva, sweat, and respiratory secretions. It works by blocking the action of acetylcholine, a neurotransmitter responsible for these physiological functions.
The MultiPort is a modular, multi-channel interface system designed for a wide range of laboratory applications. It provides simultaneous data acquisition and control capabilities across multiple channels. The core function of the MultiPort is to enable seamless integration of various sensors and devices within a laboratory environment.

More about "Glycopyrrolate"

Glycopyrrolate is a powerful synthetic anticholinergic agent that effectively reduces secretions in the salivary glands, tracheobronchial system, and gastrointestinal tract.
This versatile medication has a wide range of medical applications, including the treatment of peptic ulcers, irritable bowel syndrome, and various respiratory conditions.
The active ingredient in Glycopyrrolate, Glycopyrronium, works by blocking the action of acetylcholine, a neurotransmitter responsible for stimulating secretory glands and smooth muscle.
This mechanism of action makes Glycopyrrolate a valuable tool in managing conditions where excessive secretions or spasms need to be controlled, such as in the management of chronic obstructive pulmonary disease (COPD), asthma, and other respiratory ailments.
Beyond its primary uses, Glycopyrrolate has also been investigated for its potential in other areas, such as reducing the risk of perioperative pulmonary complications and as a pre-medication to reduce secretions prior to certain surgical procedures.
Additionally, the related compound Glycopyrronium bromide is a key ingredient in the Bevespi® Aerosphere, a combination medication used to treat COPD.
Researchers and clinicians can leverage the power of PubCompare.ai's AI-driven platform to optimize their Glycopyrrolate-related research protocols and enhance the reproducibility of their findings.
The platform's intelligent comparisons can help identify the best procedures from the available literature, preprints, and patents, streamlining the research process and ensuring reliable results.
By harnessing the insights offered by PubCompare.ai, researchers can make more informed decisions, save time, and drive their Glycopyrrolate-focused investigations forward with greater efficiency and confidence.
Whether you're investigating the use of Glycopyrrolate in the management of respiratory conditions, exploring its potential in perioperative settings, or pursuing other avenues of research, PubCompare.ai's AI-driven platform can be a valuable tool in your arsenal, helping you navigate the complexities of this versatile and widely-used medication.